Description
NAP 226-90 is a metabolite of rivastigmine that is formed by hydrolysis.
Chemical Properties
off-white to pale yellow crysta
Uses
NAP 226-90 (Rivastigmine EP Impurity A; Rivastigmin USP Related Compound C) is a S-Enantiomer metabolite of Rivastigmine, a brain selective acetylcholinesterase inhibitor.
References
[1] MD R J P. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer’s disease[J]. Clinical therapeutics, 1998, 20 4: Pages 634-647. DOI:
10.1016/s0149-2918(98)80127-6